What is Resonance Health Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Resonance Health's annualized net income for the quarter that ended in Dec. 2023 was €-0.68 Mil. Resonance Health's average shareholder tangible equity for the quarter that ended in Dec. 2023 was €4.44 Mil. Therefore, Resonance Health's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was -15.39%.
The historical rank and industry rank for Resonance Health's Return-on-Tangible-Equity or its related term are showing as below:
STU:RSN'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -15.62 Med: -6.48 Max: 50.26
Current: -14.79
During the past 13 years, Resonance Health's highest Return-on-Tangible-Equity was 50.26%. The lowest was -15.62%. And the median was -6.48%.
STU:RSN's Return-on-Tangible-Equity is ranked worse than 79.89% of 542
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs STU:RSN: -14.79
Resonance Health Return-on-Tangible-Equity Historical Data
The historical data trend for Resonance Health's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Resonance Health's Return-on-Tangible-Equity
For the Health Information Services subindustry, Resonance Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Health's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Resonance Health's Return-on-Tangible-Equity falls into.
Resonance Health Return-on-Tangible-Equity Calculation
Resonance Health's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2023) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Resonance Health (STU:RSN) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Resonance Health Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Resonance Health's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:RSN has been successfully added to your 